Steven H. Nelson - 01 May 2026 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Reporting relationship: Director
Issuer ticker: HCAT
Reported as of: 01 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 May 2026, 17:17:51 UTC
Prior SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Benjamin Landry, as Attorney-in-Fact

Key filing fact

Steven H. Nelson filed Form 4 for Health Catalyst, Inc. (HCAT) on 04 May 2026.

Key facts

This page summarizes Steven H. Nelson's Form 4 filing for Health Catalyst, Inc. (HCAT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 May 2026, 17:17.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001320490 Primary reporting owner

Nelson Steven H

Relationship: Director
Address: 10897 S. RIVER FRONT PARKWAY, SUITE 300, SOUTH JORDAN
Signature: /s/ Benjamin Landry, as Attorney-in-Fact
Signature date: 04 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCAT transaction

Common Stock

Award

Transaction value
Shares: +154,808
Change %
Price: $0.000000^*
Shares after: 154,808
Date: 01 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 33.33% of the RSUs will vest on May 1, 2027 and, thereafter, the remaining 66.67% of the RSUs will vest in 2 equal annual installments.